QurAlis to Present at H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference
- Tuesday, March 22, 2022, 7:11
- Business
- Add a comment
CAMBRIDGE, Mass., March 22, 2022 /PRNewswire/ — QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases with genetically validated targets, today announced that its CEO and co-founder,…
About the Author
adminasapcorp has written 41789 stories on this site.